Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.

INTRA-CELLULAR THERAPIES INC
ITCI
ITCI (INTRA-CELLULAR THERAPIES INC) is held by 0 institutional investors as of Q3 2026.
No verdict yet — fewer than 2 funds hold ITCI.
Top Holders
Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available
Checking access…
| Insider | Trade | Traded |
|---|---|---|
| MARCUS JOEL S | Disp $6.4M | |
| Mates Sharon | Disp $124.8M | |
| Neumann Mark | Disp $7.0M | |
| RIGGS RORY B | Disp $17.4M | |
| Salas Eduardo Rene | Disp $207K | |
| Halstead Michael | Disp $2.8M | |
| MARCUS JOEL S | Disp $1.3M | |
| VAN NOSTRAND ROBERT L | Disp $1.5M | |
| Mates Sharon | Disp $25.1M | |
| Durgam Suresh K. | Disp $5.7M |
Loading Congress trades…
| Filer | Stake | Filed |
|---|---|---|
| JPMORGAN CHASE & CO. | 0.0% |
Continue exploring
Similar stocks
347 holders · $19.6B
320 holders · $348.1B
288 holders · $546.5B
273 holders · $284.2B
269 holders · $133.7B
269 holders · $65.7B
260 holders · $36.2B
249 holders · $48.1B
242 holders · $48.9B
242 holders · $110.7B
Questions investors ask about ITCI
Who owns ITCI?
0 institutional investors held ITCI on September 30, 2026, according to their 13F filings.
How many hedge funds hold ITCI?
0 institutional investors reported ITCI in their 13F filings for the quarter ended September 30, 2026.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer